Blog

Global study on the accuracy of HER2-low diagnoses among 77 pathologists from 14 countries

Photo from oncology-central.com

Aug 12, 2024, 14:48

Global study on the accuracy of HER2-low diagnoses among 77 pathologists from 14 countries

Paolo Tarantino, Clinical Research Fellow at shared a recent article by Josef Ruschoff on X, commenting:

“Global study on the accuracy of HER2-low (vs 0) diagnoses among 77 pathologists from 14 countries 74.6% agreement in the HER2-0 category, which improved after training Though the HER2 categories have already changed, w/ the emergence of HER2 ultralow.”

Title: Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast Cancer

Authors: Josef Rüschoff, Alexander Penner, Ian O Ellis, M Elizabeth Hale Hammond, Annette Lebeau, Robert Y Osamura, Fréderique Penault-Llorca, Federico Rojo, Chirag Desai, Akira Moh, Neil Atkey, Gudrun Baenfer, Andreas H Scheel, Corrado D’Arrigo, Hans-Ulrich Schildhaus, Giuseppe Viale.

Global study

Source: Paolo Tarantino/X

Alexander Penner cancer Dana-Farber Cancer Institute Giuseppe Viale Global study Hans-Ulrich Schildhaus Ian O Ellis Josef Ruschoff OncoDaily Oncology Paolo Tarantino

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity